 According to data published in the scientific journal Cureus, adults with a recent history of cannabis use are twice as less likely to be diagnosed with the most common type of liver cancer (hepatocellular carcinoma), than those who’ve never used cannabis.
A team of researchers affiliated with the Cleveland Clinic and with Georgetown University Hospital in Washington, DC assessed over one million subjects. They reported that those who with current cannabis use were “55 percent less likely to have [live cancer] HCC compared to non-cannabis users.” The authors suggested further testing to better understand the way cannabis compenents, particularly CBD, may possibly be regulating these cancer cells. Cannabinoids have shown anti-cancer activity in cellular models and a limited number of case reports, as well as observational data that’s shown an association between cannabis use and a reduced risk of head and neck cancers. Comments are closed.
|
RSS Feed